Which DOAC has lower risk of complicated upper GI bleeding in Asians?
22 May 2026
bởiKanas Chan
Apixaban showed a lower 2-year risk of complicated upper gastrointestinal bleeding (UGIB) vs edoxaban and rivaroxaban, but not dabigatran, in patients without prior anticoagulant exposure, according to an industry-independent, Asian population–based cohort study conducted by researchers from the Chinese University of Hong Kong (CUHK).
